• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

18.62 -0.24 (-1.27%)
Streaming Delayed Price Updated: 1:54 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Limited - American Depositary Shares

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
News headline image
89 Biggest Movers From Friday ↗
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy. 
Via Benzinga
News headline image
Zai Lab's Niraparib Shows 3X Longer PFS Compared to Placebo In Ovarian Cancer ↗
March 21, 2022
Zai Lab Limited (NASDAQ: ZLAB)  
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
June 14, 2022
On Tuesday, 951 companies hit new 52-week lows. 
Via Benzinga
News headline image
CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment ↗
June 07, 2022
Key Takeaways: CStone brought four products to market last year, and its losses have surged due to growing R&D and sales spending Appointment of chairman with close ties... 
Via Benzinga
News headline image
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer
June 03, 2022
From Novocure
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
May 11, 2022
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
May 11, 2022
Good morning and welcome back for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
News headline image
110 Biggest Movers From Friday ↗
May 16, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital. 
Via Benzinga
News headline image
52 Stocks Moving In Wednesday's Mid-Day Session ↗
May 11, 2022
Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247... 
Via Benzinga
News headline image
34 Stocks Moving in Wednesday's Pre-Market Session ↗
May 11, 2022
Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share. 
Via Benzinga
News headline image
Zai Lab: Q1 Earnings Insights ↗
May 10, 2022
Zai Lab (NASDAQ:ZLAB) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Zai Lab beat estimated earnings by... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗
May 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Zai Lab's Earnings Outlook ↗
May 09, 2022
Zai Lab (NASDAQ:ZLAB) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that Zai Lab will report... 
Via Benzinga
News headline image
Zai Lab Limited (NASDAQ: ZLAB) Investor Alert: Investigation over Possible Violations of Securities Laws ↗
April 25, 2022
San Diego, CA -- (SBWIRE) -- 04/25/2022 -- Zai Lab Limited is under investigation over potential securities laws violations by Zai Lab Limited in connection with certain financial statements. 
Via SBWire
News headline image
Earnings Scheduled For May 10, 2022 ↗
May 10, 2022
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million. 
Via Benzinga
News headline image
92 Biggest Movers From Friday ↗
May 09, 2022
Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... 
Via Benzinga
News headline image
HFCAA News: 128 Chinese Stocks the SEC Could Delist ↗
May 05, 2022
The SEC has released a massive list of Chinese stocks that could face delisting on Holding Foreign Companies Accountable Act news. 
Via InvestorPlace
News headline image
Cancer Drug Maker BeiGene Takes Action to Mitigate Delisting Risk ↗
April 11, 2022
Key Takeaways: BeiGene has switched auditors for its New York listing to a U.S. company from a Chinese one in a move to comply with U.S. law The change could reduce the company... 
Via Benzinga
News headline image
The Gift Chinese Regulators Just Gave Tech Stocks Like Alibaba And BeiGene ↗
April 04, 2022
Auditing issues persist for some 270 companies trading in the U.S. But they could ease. 
Via Investor's Business Daily
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Zai Lab Limited with Losses of $100,000 to Contact the Firm
April 04, 2022
From The Schall Law Firm
Via Business Wire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Zai Lab Limited with Losses of $100,000 to Contact the Firm
April 01, 2022
From The Schall Law Firm
Via Business Wire
News headline image
Most Chinese Biotech Stocks Can Continue US Listing After New Audit Framework ↗
April 01, 2022
 
Via Benzinga
News headline image
EQUITY ALERT: Rosen Law Firm Encourages Zai Lab Limited Investors with Losses in Excess of $100K to Inquire About Securities Class Action Investigation – ZLAB
March 31, 2022
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs ↗
March 28, 2022
As these Chinese stocks face delisting, some may provide a contrarian play on improving relations between the U.S. and China. 
Via InvestorPlace
News headline image
Which Chinese Stocks Could Get Delisted? 6 Companies to Watch. ↗
March 25, 2022
Today, news that Weibo has been added to the SEC's list of at-risk companies for delisting has investors selling Chinese stocks in a big way. 
Via InvestorPlace
News headline image
80 Biggest Movers From Yesterday ↗
March 17, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares gained 86.7% to close at $0.5150 on Wednesday after the company announced FDA clearance of its IND for SON-... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) shares rose 114.0% to $0.59 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of... 
Via Benzinga
News headline image
61 Stocks Moving In Wednesday's Mid-Day Session ↗
March 16, 2022
Gainers Fangdd Network Group Ltd. (NASDAQ: DUO) jumped 70.3% to $0.4550. Shares of Chinese companies traded higher following a Chinese state media report indicating China's... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
March 16, 2022
Gainers Sonnet BioTherapeutics (NASDAQ:SONN) stock rose 85.6% to $0.51 during Wednesday's pre-market session. The company's market cap stands at $30.8 million.... 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 13-19): Bristol-Myers Squibb's Melanoma Drug Decision, Multiple Conference Presentations And Earnings Dominate Proceedings ↗
March 13, 2022
Biotech stocks pulled back for a second week running, as the Ukraine war cast its cloud on the broader market. Dwindling earnings news flow and company-specific developments... 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap